Trial Profile
A phase I/II trial to investigate PSA/IL-2/GM-CSF for the treatment of prostate cancer
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 08 Sep 2021
Price :
$35
*
At a glance
- Drugs PSA-IL2-GM-CSF vaccine (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 30 Jan 2016 Results published on the OncBioMune website.
- 30 Jan 2016 New trial record